Rogerio Lilenbaum Selected Research

Rogerio Lilenbaum Research Topics

Disease

28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2003
11	Neoplasms (Cancer) 12/2018 - 07/2005
4	Lung Neoplasms (Lung Cancer) 09/2015 - 11/2003
3	Diarrhea 12/2020 - 02/2008
3	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2009
3	Disease Progression 01/2015 - 11/2006
2	Exanthema (Rash) 12/2020 - 02/2008
2	Brain Neoplasms (Brain Tumor) 01/2020 - 09/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015 - 01/2005
2	Neutropenia 06/2010 - 04/2007
2	Vomiting 03/2008 - 02/2008
2	Leukemia 03/2008 - 07/2005
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Pain (Aches) 12/2018
1	Multiple Chronic Conditions 09/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Anorexia 03/2008
1	Hyperglycemia 03/2008
1	Infections 03/2008
1	Nausea 03/2008
1	Stomatitis 03/2008
1	Dyspnea (Shortness of Breath) 03/2008
1	Alopecia (Baldness) 02/2008
1	Fatigue 02/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2008
1	Hemoptysis 09/2007
1	Hemorrhage 12/2006
1	Pericardial Effusion 05/2006

Drug/Important Bio-Agent (IBA)

4	Cetuximab (Erbitux)FDA Link 12/2020 - 06/2005
4	Gemcitabine FDA Link 01/2015 - 05/2006
4	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 05/2006
4	Docetaxel (Taxotere)FDA Link 06/2010 - 10/2006
4	Bevacizumab (Avastin)FDA Link 05/2008 - 03/2006
2	PlatinumIBA 01/2018 - 01/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2015 - 02/2008
2	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 06/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 12/2006
2	ErbB Receptors (EGF Receptor)IBA 09/2013 - 11/2010
2	Bortezomib (Velcade)FDA Link 09/2009 - 03/2006
1	AfatinibIBA 12/2020
1	pembrolizumabIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 12/2018
1	130-nm albumin-bound paclitaxelIBA 01/2015
1	Gefitinib (Iressa)FDA Link 09/2013
1	Tyrosine Kinase InhibitorsIBA 11/2010
1	tanespimycin (17AAG)IBA 11/2010
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2010
1	Cisplatin (Platino)FDA LinkGeneric 06/2010
1	Filgrastim (Neupogen)FDA Link 06/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2010
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2009
1	AlbuminsIBA 07/2009
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2008
1	Hemoglobins (Hemoglobin)IBA 03/2008
1	Monoclonal AntibodiesIBA 12/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2006
1	Celecoxib (Celebrex)FDA Link 10/2006
1	Antisense OligonucleotidesIBA 05/2006
1	aprinocarsenIBA 05/2006
1	Pemetrexed (MTA)FDA Link 03/2006
1	TER 286 (TLK286)IBA 03/2006
1	Epothilones (Epothilone)IBA 03/2006
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2003

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2018 - 03/2003
10	Therapeutics 01/2018 - 01/2003
5	Radiotherapy 01/2020 - 01/2005
2	Immunotherapy 01/2020 - 01/2017
2	Combined Modality Therapy 06/2010 - 01/2005
1	Terminal Care (Care, Terminal) 01/2018
1	Time-to-Treatment 01/2018
1	Induction Chemotherapy 01/2015
1	Adjuvant Chemotherapy 09/2013
1	Combination Drug Therapy (Combination Chemotherapy) 07/2009